Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 10, 2011

Westburg to Supply Denator’s Stabilizor System in Benelux Region

  • Denator signed an agreement under which Westburg will become the sole distributor of the company’s Stabilizor® technology and accessories in the Benelux region. The system uses heat-inactivation technology to stabilize tissue samples at the moment of sampling and to preserve sample components in their in vivo state.

    Denator says many of its current clients have used the system to discover new proteins and peptides and increase the reproducibility of their protein-analysis workflows. The agreement is part of Denator’s effort to expand its distributor network in what it considers strategically important regions including Benelux, Japan, Switzerland, and the U.K. The company, which sells its products directly in the U.S., reported deals with distributors covering Japan and Switzerland last year and in the U.K. and Ireland in 2009.

    Denator introduced the Stabilizor system in 2008 and last November obtained SEK 12 million (about $1.8 million) in a fifth financing round intended to fund global marketing and sales activities and focus development of its product portfolio in key markets.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »